Myocardial perfusion 320-row multidetector computed tomography–guided treatment strategy for the clinical management of patients with recent acute-onset chest pain : Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial - 03/09/16
, Jesper J. Linde, MD, PhD a, Jens D. Hove, MD, PhD b, Jan R. Petersen, MD, PhD c, Tem B.S. Jørgensen, MD c, Jawdat Abdulla, MD, PhD d, Merete Heitmann, MD, PhD e, Charlotte Kragelund, MD, PhD f, Thomas Fritz Hansen, MD, PhD, DMSc g, Patricia M. Udholm, BM, Sc a, Christian Pihl, BM, Sc a, J. Tobias Kühl, MD, PhD a, Thomas Engstrøm, MD, PhD, DMSc a, Jan Skov Jensen, MD, PhD, DMSc g, Dan E. Høfsten, MD, PhD a, Henning Kelbæk, MD, PhD, DMSc h, Klaus F. Kofoed, MD, PhD, DMSc a, iRésumé |
Aims |
Patients admitted with chest pain are a diagnostic challenge because the majority does not have coronary artery disease (CAD). Assessment of CAD with coronary computed tomography angiography (CCTA) is safe, cost-effective, and accurate, albeit with a modest specificity. Stress myocardial computed tomography perfusion (CTP) has been shown to increase the specificity when added to CCTA, without lowering the sensitivity. This article describes the design of a randomized controlled trial, CATCH-2, comparing a clinical diagnostic management strategy of CCTA alone against CCTA in combination with CTP.
Methods |
Patients with acute-onset chest pain older than 50 years and with at least one cardiovascular risk factor for CAD are being prospectively enrolled to this study from 6 different clinical sites since October 2013. A total of 600 patients will be included. Patients are randomized 1:1 to clinical management based on CCTA or on CCTA in combination with CTP, determining the need for further testing with invasive coronary angiography including measurement of the fractional flow reserve in vessels with coronary artery lesions. Patients are scanned with a 320-row multidetector computed tomography scanner. Decisions to revascularize the patients are taken by the invasive cardiologist independently of the study allocation. The primary end point is the frequency of revascularization. Secondary end points of clinical outcome are also recorded.
Discussion |
The CATCH-2 will determine whether CCTA in combination with CTP is diagnostically superior to CCTA alone in the management of patients with acute-onset chest pain.
Le texte complet de cet article est disponible en PDF.Plan
Vol 179
P. 127-135 - septembre 2016 Retour au numéro
Article précédent
- Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome
- Yongchen Hao, Jing Liu, Jun Liu, Sidney C. Smith, Yong Huo, Gregg C. Fonarow, Changsheng Ma, Junbo Ge, Kathryn A. Taubert, Louise Morgan, Yang Guo, Qian Zhang, Wei Wang, Dong Zhao, CCC-ACS Investigators
- Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH)
- Jens Jakob Thune, Steen Pehrson, Jens Cosedis Nielsen, Jens Haarbo, Lars Videbæk, Eva Korup, Gunnar Jensen, Per Hildebrandt, Flemming Hald Steffensen, Niels Eske Bruun, Hans Eiskjær, Axel Brandes, Anna Margrethe Thøgersen, Kenneth Egstrup, Jesper Hastrup-Svendsen, Dan Eik Høfsten, Christian Torp-Pedersen, Lars Køber
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?